Back to NVSView Full Landscape
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
3 competitors in Geographic Atrophy Secondary to Age-related Macular Degeneration
APLSPEGCETACOPLAN (APL-2)
Phase 3APLSAPL-3007, pegcetacoplan (APL-2)
Phase 2BIIBAPL-3007, pegcetacoplan (APL-2)
Phase 2Drug Information
Target Indication
Geographic Atrophy Secondary to Age-related Macular Degeneration
Clinical Trial
NCT07441642Last updated: 7/11/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts